135 related articles for article (PubMed ID: 6420159)
1. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
Daniel CP; Gaskell SJ; Nicholson RI
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
[TBL] [Abstract][Full Text] [Related]
2. Anti-oestrogen action in experimental breast cancer.
Jordan VC; Naylor KE; Dix CJ; Prestwich G
Recent Results Cancer Res; 1980; 71():30-44. PubMed ID: 6768113
[No Abstract] [Full Text] [Related]
3. Comparative pharmacodynamic analysis of TAT-59 and tamoxifen in rats bearing DMBA-induced mammary carcinoma.
Toko T; Shibata J; Sugimoto Y; Yamaya H; Yoshida M; Ogawa K; Matsushima E
Cancer Chemother Pharmacol; 1995; 37(1-2):7-13. PubMed ID: 7497599
[TBL] [Abstract][Full Text] [Related]
4. The effect of pregnant mares serum gonadotrophin on the response of DMBA induced rat mammary tumours to tamoxifen or oestrogen.
Clark ER; Robinson SP; Whitaker EM; Zoltowski JA
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1843-50. PubMed ID: 2517258
[TBL] [Abstract][Full Text] [Related]
5. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
Jordan VC
Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
[TBL] [Abstract][Full Text] [Related]
6. Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.
Shigaki N; Kimura M; Takano S; Fujino N; Akagi M
Jpn J Surg; 1987 Sep; 17(5):395-401. PubMed ID: 3123757
[TBL] [Abstract][Full Text] [Related]
7. Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model.
Robinson SP; Mauel DA; Jordan VC
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1817-21. PubMed ID: 2975594
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen levels in cytosol and KCl-nuclear extracts of breast tumours from tamoxifen treated patients by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM).
Murphy C; Fotsis T; Pantzar P; Adlercreutz H; Martin F
J Steroid Biochem; 1987 Dec; 28(6):609-18. PubMed ID: 3695512
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen as an anti-tumour agent: effect on oestrogen binding.
Jordan VC; Dowse LJ
J Endocrinol; 1976 Feb; 68(02):297-303. PubMed ID: 176295
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
11. Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.
Görlich M; Winterfeld G; Hauff P; Arnold W; Fichtner I; Staab HJ
J Cancer Res Clin Oncol; 1992; 119(2):97-100. PubMed ID: 1429832
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors.
Pento JT; Magarian RA; King MM
Cancer Lett; 1982; 15(3):261-9. PubMed ID: 6811128
[No Abstract] [Full Text] [Related]
13. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
di Salle E; Zaccheo T; Ornati G
J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of tamoxifen in laboratory animals.
Jordan VC; Allen KE; Dix CJ
Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic, pituitary and uterine cytoplasmic and nuclear oestrogen receptors and their relationship to the serum concentration of tamoxifen and its metabolite, 4-hydroxytamoxifen, in the ovariectomized rat.
Bowman SP; Leake A; Morris ID
J Endocrinol; 1982 Aug; 94(2):167-75. PubMed ID: 7108408
[TBL] [Abstract][Full Text] [Related]
16. Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas.
Maucher A; von Angerer E
J Cancer Res Clin Oncol; 1994; 120(8):502-4. PubMed ID: 8207051
[TBL] [Abstract][Full Text] [Related]
17. Comparative antioestrogen action in experimental breast cancer.
Jordan VC
Adv Exp Med Biol; 1981; 138():165-78. PubMed ID: 6805259
[No Abstract] [Full Text] [Related]
18. Effects of OK-432 (Picibanil) on estrogen receptor levels and tamoxifen treatment in 7,12-dimethylbenz[a]anthracene-induced rat mammary cancers.
Iino Y; Ogawa T; Yoshida M; Izuo M; Takikawa H
Oncology; 1990; 47(2):185-90. PubMed ID: 2107482
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
Wei LL; Mangel WF; Katzenellenbogen BS
J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
[TBL] [Abstract][Full Text] [Related]
20. Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen.
Hollingsworth AB; Lerner MR; Lightfoot SA; Wilkerson KB; Hanas JS; McCay PB; Brackett DJ
Breast Cancer Res Treat; 1998 Jan; 47(1):63-70. PubMed ID: 9493977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
